CRANE NXT CO (CXT) Fundamental Analysis & Valuation

NYSE:CXTUS2244411052

Current stock price

42.27 USD
-0.58 (-1.35%)
At close:
42.27 USD
0 (0%)
After Hours:

This CXT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. CXT Profitability Analysis

1.1 Basic Checks

  • CXT had positive earnings in the past year.
  • In the past year CXT had a positive cash flow from operations.
  • CXT had positive earnings in each of the past 5 years.
  • CXT had a positive operating cash flow in each of the past 5 years.
CXT Yearly Net Income VS EBIT VS OCF VS FCFCXT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • With a decent Return On Assets value of 5.30%, CXT is doing good in the industry, outperforming 72.58% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 12.74%, CXT belongs to the top of the industry, outperforming 80.65% of the companies in the same industry.
  • The Return On Invested Capital of CXT (8.78%) is better than 79.03% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CXT is above the industry average of 8.67%.
Industry RankSector Rank
ROA 5.3%
ROE 12.74%
ROIC 8.78%
ROA(3y)7.07%
ROA(5y)6.96%
ROE(3y)16.14%
ROE(5y)16.86%
ROIC(3y)11.44%
ROIC(5y)10.83%
CXT Yearly ROA, ROE, ROICCXT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • With an excellent Profit Margin value of 9.80%, CXT belongs to the best of the industry, outperforming 84.68% of the companies in the same industry.
  • In the last couple of years the Profit Margin of CXT has grown nicely.
  • CXT has a Operating Margin of 17.59%. This is amongst the best in the industry. CXT outperforms 92.74% of its industry peers.
  • In the last couple of years the Operating Margin of CXT has grown nicely.
  • CXT has a Gross Margin of 43.20%. This is in the better half of the industry: CXT outperforms 75.00% of its industry peers.
  • In the last couple of years the Gross Margin of CXT has grown nicely.
Industry RankSector Rank
OM 17.59%
PM (TTM) 9.8%
GM 43.2%
OM growth 3Y-11.5%
OM growth 5Y9.05%
PM growth 3Y-16.95%
PM growth 5Y5.97%
GM growth 3Y-3.13%
GM growth 5Y3.98%
CXT Yearly Profit, Operating, Gross MarginsCXT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 10 20 30 40

2

2. CXT Health Analysis

2.1 Basic Checks

  • CXT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, CXT has more shares outstanding
  • CXT has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, CXT has a worse debt to assets ratio.
CXT Yearly Shares OutstandingCXT Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
CXT Yearly Total Debt VS Total AssetsCXT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • An Altman-Z score of 1.95 indicates that CXT is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • CXT has a Altman-Z score of 1.95. This is in the lower half of the industry: CXT underperforms 66.13% of its industry peers.
  • CXT has a debt to FCF ratio of 6.27. This is a slightly negative value and a sign of low solvency as CXT would need 6.27 years to pay back of all of its debts.
  • CXT's Debt to FCF ratio of 6.27 is in line compared to the rest of the industry. CXT outperforms 57.26% of its industry peers.
  • A Debt/Equity ratio of 0.89 indicates that CXT is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.89, CXT is doing worse than 87.10% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF 6.27
Altman-Z 1.95
ROIC/WACC0.97
WACC9.09%
CXT Yearly LT Debt VS Equity VS FCFCXT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.3 Liquidity

  • CXT has a Current Ratio of 1.26. This is a normal value and indicates that CXT is financially healthy and should not expect problems in meeting its short term obligations.
  • CXT has a worse Current ratio (1.26) than 79.84% of its industry peers.
  • A Quick Ratio of 0.94 indicates that CXT may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.94, CXT is not doing good in the industry: 81.45% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.94
CXT Yearly Current Assets VS Current LiabilitesCXT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

4

3. CXT Growth Analysis

3.1 Past

  • The earnings per share for CXT have decreased by -4.92% in the last year.
  • Measured over the past 5 years, CXT shows a small growth in Earnings Per Share. The EPS has been growing by 1.12% on average per year.
  • CXT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.43%.
  • Measured over the past years, CXT shows a decrease in Revenue. The Revenue has been decreasing by -9.71% on average per year.
EPS 1Y (TTM)-4.92%
EPS 3Y-19.21%
EPS 5Y1.12%
EPS Q2Q%5.83%
Revenue 1Y (TTM)11.43%
Revenue growth 3Y7.33%
Revenue growth 5Y-9.71%
Sales Q2Q%19.49%

3.2 Future

  • CXT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.32% yearly.
  • Based on estimates for the next years, CXT will show a small growth in Revenue. The Revenue will grow by 5.29% on average per year.
EPS Next Y6.3%
EPS Next 2Y8.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.38%
Revenue Next 2Y5.29%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CXT Yearly Revenue VS EstimatesCXT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CXT Yearly EPS VS EstimatesCXT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

8

4. CXT Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 10.41 indicates a reasonable valuation of CXT.
  • 93.55% of the companies in the same industry are more expensive than CXT, based on the Price/Earnings ratio.
  • CXT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.70.
  • Based on the Price/Forward Earnings ratio of 9.79, the valuation of CXT can be described as reasonable.
  • 91.13% of the companies in the same industry are more expensive than CXT, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.84, CXT is valued rather cheaply.
Industry RankSector Rank
PE 10.41
Fwd PE 9.79
CXT Price Earnings VS Forward Price EarningsCXT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • 90.32% of the companies in the same industry are more expensive than CXT, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, CXT is valued cheaper than 84.68% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.07
EV/EBITDA 8.22
CXT Per share dataCXT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The excellent profitability rating of CXT may justify a higher PE ratio.
PEG (NY)1.65
PEG (5Y)9.29
EPS Next 2Y8.32%
EPS Next 3YN/A

6

5. CXT Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.51%, CXT has a reasonable but not impressive dividend return.
  • CXT's Dividend Yield is rather good when compared to the industry average which is at 0.47. CXT pays more dividend than 93.55% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, CXT has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.51%

5.2 History

  • On average, the dividend of CXT grows each year by 6.42%, which is quite nice.
  • CXT has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)6.42%
Div Incr Years0
Div Non Decr Years0
CXT Yearly Dividends per shareCXT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 24.82% of the earnings are spent on dividend by CXT. This is a low number and sustainable payout ratio.
  • CXT's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP24.82%
EPS Next 2Y8.32%
EPS Next 3YN/A
CXT Yearly Income VS Free CF VS DividendCXT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
CXT Dividend Payout.CXT Dividend Payout, showing the Payout Ratio.CXT Dividend Payout.PayoutRetained Earnings

CXT Fundamentals: All Metrics, Ratios and Statistics

CRANE NXT CO

NYSE:CXT (3/13/2026, 8:19:09 PM)

After market: 42.27 0 (0%)

42.27

-0.58 (-1.35%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-11
Earnings (Next)05-05
Inst Owners113.86%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner Change4.91%
Market Cap2.43B
Revenue(TTM)1.66B
Net Income(TTM)154.70M
Analysts81.82
Price Target91.36 (116.13%)
Short Float %12.59%
Short Ratio8.86
Dividend
Industry RankSector Rank
Dividend Yield 1.51%
Yearly Dividend0.68
Dividend Growth(5Y)6.42%
DP24.82%
Div Incr Years0
Div Non Decr Years0
Ex-Date02-27
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.72%
Min EPS beat(2)0.03%
Max EPS beat(2)1.41%
EPS beat(4)3
Avg EPS beat(4)1.08%
Min EPS beat(4)-1.06%
Max EPS beat(4)3.95%
EPS beat(8)6
Avg EPS beat(8)1.32%
EPS beat(12)10
Avg EPS beat(12)6.53%
EPS beat(16)13
Avg EPS beat(16)6.15%
Revenue beat(2)1
Avg Revenue beat(2)-0.28%
Min Revenue beat(2)-2.45%
Max Revenue beat(2)1.89%
Revenue beat(4)2
Avg Revenue beat(4)-0.1%
Min Revenue beat(4)-2.54%
Max Revenue beat(4)2.69%
Revenue beat(8)4
Avg Revenue beat(8)0.56%
Revenue beat(12)6
Avg Revenue beat(12)0.73%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.09%
PT rev (3m)-3.98%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-5.05%
EPS NY rev (3m)-8.31%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.02%
Revenue NY rev (1m)-0.28%
Revenue NY rev (3m)-0.51%
Valuation
Industry RankSector Rank
PE 10.41
Fwd PE 9.79
P/S 1.54
P/FCF 14.07
P/OCF 11.2
P/B 2
P/tB N/A
EV/EBITDA 8.22
EPS(TTM)4.06
EY9.6%
EPS(NY)4.32
Fwd EY10.21%
FCF(TTM)3
FCFY7.11%
OCF(TTM)3.77
OCFY8.93%
SpS27.49
BVpS21.14
TBVpS-9.06
PEG (NY)1.65
PEG (5Y)9.29
Graham Number43.94
Profitability
Industry RankSector Rank
ROA 5.3%
ROE 12.74%
ROCE 12.04%
ROIC 8.78%
ROICexc 9.45%
ROICexgc 35.12%
OM 17.59%
PM (TTM) 9.8%
GM 43.2%
FCFM 10.93%
ROA(3y)7.07%
ROA(5y)6.96%
ROE(3y)16.14%
ROE(5y)16.86%
ROIC(3y)11.44%
ROIC(5y)10.83%
ROICexc(3y)12.73%
ROICexc(5y)12.19%
ROICexgc(3y)46.7%
ROICexgc(5y)44.71%
ROCE(3y)14.96%
ROCE(5y)14.57%
ROICexgc growth 3Y-23.13%
ROICexgc growth 5Y12.65%
ROICexc growth 3Y-18.15%
ROICexc growth 5Y5.03%
OM growth 3Y-11.5%
OM growth 5Y9.05%
PM growth 3Y-16.95%
PM growth 5Y5.97%
GM growth 3Y-3.13%
GM growth 5Y3.98%
F-Score4
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF 6.27
Debt/EBITDA 2.86
Cap/Depr 43.72%
Cap/Sales 2.8%
Interest Coverage 5.31
Cash Conversion 57.22%
Profit Quality 111.57%
Current Ratio 1.26
Quick Ratio 0.94
Altman-Z 1.95
F-Score4
WACC9.09%
ROIC/WACC0.97
Cap/Depr(3y)44.3%
Cap/Depr(5y)36.54%
Cap/Sales(3y)2.63%
Cap/Sales(5y)2.17%
Profit Quality(3y)119.51%
Profit Quality(5y)128.53%
High Growth Momentum
Growth
EPS 1Y (TTM)-4.92%
EPS 3Y-19.21%
EPS 5Y1.12%
EPS Q2Q%5.83%
EPS Next Y6.3%
EPS Next 2Y8.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.43%
Revenue growth 3Y7.33%
Revenue growth 5Y-9.71%
Sales Q2Q%19.49%
Revenue Next Year6.38%
Revenue Next 2Y5.29%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-0.68%
EBIT growth 3Y-5.02%
EBIT growth 5Y-1.54%
EBIT Next Year18.85%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y6.61%
FCF growth 3Y-11.36%
FCF growth 5Y-6.44%
OCF growth 1Y2.51%
OCF growth 3Y-7.59%
OCF growth 5Y-4.84%

CRANE NXT CO / CXT Fundamental Analysis FAQ

What is the fundamental rating for CXT stock?

ChartMill assigns a fundamental rating of 5 / 10 to CXT.


Can you provide the valuation status for CRANE NXT CO?

ChartMill assigns a valuation rating of 8 / 10 to CRANE NXT CO (CXT). This can be considered as Undervalued.


What is the profitability of CXT stock?

CRANE NXT CO (CXT) has a profitability rating of 8 / 10.


How financially healthy is CRANE NXT CO?

The financial health rating of CRANE NXT CO (CXT) is 2 / 10.


Is the dividend of CRANE NXT CO sustainable?

The dividend rating of CRANE NXT CO (CXT) is 6 / 10 and the dividend payout ratio is 24.82%.